Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and sq-23377

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with sq-23377 in 1 studies

Compound Research Comparison

Studies
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)
Trials
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)
Recent Studies (post-2010)
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)
Studies
(sq-23377)
Trials
(sq-23377)
Recent Studies (post-2010) (sq-23377)
791164,38510493

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fagan, JM; Waxman, L1

Other Studies

1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and sq-23377

ArticleYear
The ATP-independent pathway in red blood cells that degrades oxidant-damaged hemoglobin.
    The Journal of biological chemistry, 1992, Nov-15, Volume: 267, Issue:32

    Topics: Adenosine Triphosphate; Animals; Azides; Calcimycin; Cations, Divalent; Cysteine Proteinase Inhibitors; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Hemoglobins; Hydrogen Peroxide; Ionomycin; Kinetics; Leucine; Male; Oxidants; Phenylhydrazines; Pyrimidinones; Rabbits; Rats

1992